Irish pharmaceutical company Allergan plc (NYSE:AGN) reported on Monday the receipt of clearance from the US FDA for the CoolTone device for improvement of abdominal tone, strengthening of the abdominal muscles, development for firmer abdomen as well as for strengthening, toning and firming of buttocks and thighs.

The CoolTone technology, which uses the magnetic muscle stimulation (MMS), penetrates into the muscle layers and induces involuntary muscle contractions. The body responds to these contractions by strengthening its muscle fibres, resulting in improved muscle conditioning. The CoolTone strengthens, tones and firms the muscles in the treated area. It has 50% more magnetic intensity than the leading competitor at the point of contact, said the company.

Following the US FDA clearance, the company is now taking orders for the CoolTone device and first units will ship early in the fourth quarter of this year.

According to the company, the CoolSculpting is a non-surgical, clinically proven treatment that selectively reduces unwanted fat using a patented cooling technology. Cleared by the US FDA, CoolSculpting works by gently cooling targeted fat cells in the body to induce a natural, controlled elimination of fat cells without affecting surrounding tissue and the treated fat cells are gone for good.